HighTower Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$152K Sell
2025
Q1
$128K Sell
2024
Q4
$132K Sell
2024
Q3
$146K Sell
2024
Q2
$124K Buy
2024
Q1
$92K Hold
2023
Q4
$109K Buy
2023
Q3
$126K Sell
2023
Q2
$131K Buy
2021
Q1
Sell
2020
Q4
$191K Buy
2014
Q4
Sell
2014
Q3
$127K Buy